[BDRX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
30-Dec-2022
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 0.00%
YoY- -99.31%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 42 149 149 116 116 234 234 -68.14%
PBT -1,815 -1,928 -1,928 -2,545 -2,545 -1,699 -1,699 4.49%
Tax 59 144 144 248 248 169 169 -50.38%
NP -1,756 -1,784 -1,784 -2,298 -2,298 -1,531 -1,531 9.56%
Tax Rate - - - - - - - -
Total Cost 1,797 1,933 1,933 2,413 2,413 1,765 1,765 1.20%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -4,230.12 -1,197.32 -1,197.32 -1,989.18 -1,989.18 -654.06 -654.06 246.73%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -1.32 -7.19 -7.19 -185.31 -185.31 -124.33 -124.33 -95.15%
EPS Diluted -1.32 -7.19 -7.19 -185.31 -185.31 -124.33 -124.33 -95.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.